Ligand Pharmaceuticals (LGND) Depreciation and Depletion (2012 - 2026)
Ligand Pharmaceuticals (LGND) reported Depreciation and Depletion of $119000.0 for Q1 2026, down 76.8% on a YoY basis from $513000.0 in Q1 2025, and up 133.33% sequentially from $51000.0 in Q4 2025.
Ligand Pharmaceuticals (LGND) Depreciation and Depletion (2012 - 2026) Analysis & Trends
Ligand Pharmaceuticals (LGND) has 8 years of Depreciation and Depletion data on file, last reported at $119000.0 in Q1 2026.
- For the quarter ending Q1 2026, Depreciation and Depletion fell 76.8% year-over-year to $119000.0; the trailing twelve-month figure through Mar 2026 stood at $606000.0 (down 72.87% YoY), and the FY2025 full-year result was $1.0 million, down 56.52% from the prior year.
- Depreciation and Depletion rose to $119000.0 in Q1 2026, from $51000.0 in the prior quarter.
- In the past five years, Depreciation and Depletion ranged from a high of $736000.0 in Q3 2024 to a low of $51000.0 in Q4 2025.
- A 3-year average of $379888.9 and a median of $389000.0 in 2024 frame the typical range for Depreciation and Depletion.
- Peak annual rise in Depreciation and Depletion reached 11.4% in 2025, while the deepest fall reached 86.89% in 2025.
- Tracing LGND's Depreciation and Depletion over 3 years: stood at $389000.0 in 2024, then tumbled by 86.89% to $51000.0 in 2025, then soared by 133.33% to $119000.0 in 2026.
- Business Quant data shows LGND's Depreciation and Depletion at $119000.0 in Q1 2026, $51000.0 in Q4 2025, and $172000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 39.39 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.20 Mn |
| 10 | Ligand Pharmaceuticals | 6.05 Bn | 5.27 Bn | 48.45 Mn | 119,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 119,000.00 |
| Mar 31, 2026 | 119,000.00 |
| Dec 31, 2025 | 51,000.00 |
| Dec 31, 2025 | 51,000.00 |
| Sep 30, 2025 | 172,000.00 |
| Sep 30, 2025 | 172,000.00 |
| Jun 30, 2025 | 264,000.00 |
| Jun 30, 2025 | 264,000.00 |
| Mar 31, 2025 | 513,000.00 |
| Mar 31, 2025 | 513,000.00 |
| Dec 31, 2024 | 389,000.00 |
| Dec 31, 2024 | 389,000.00 |
| Sep 30, 2024 | 736,000.00 |
| Sep 30, 2024 | 736,000.00 |
| Jun 30, 2024 | 596,000.00 |
| Jun 30, 2024 | 596,000.00 |
| Mar 31, 2024 | 579,000.00 |
| Mar 31, 2024 | 579,000.00 |
| Jun 30, 2016 | 100,000.00 |
| Jun 30, 2016 | 100,000.00 |